NexgenRx Inc.
NXG.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 883.30K | -129.70K | 428.20K | 255.50K | 367.30K |
| Total Depreciation and Amortization | 55.90K | 48.80K | 227.50K | 233.40K | 218.80K |
| Total Amortization of Deferred Charges | 111.20K | 146.20K | -- | -- | -- |
| Total Other Non-Cash Items | -12.00K | 600.30K | -11.20K | -11.50K | -9.00K |
| Change in Net Operating Assets | -993.10K | 1.27M | -5.00K | 274.40K | -331.50K |
| Cash from Operations | 45.20K | 1.94M | 639.50K | 751.80K | 245.70K |
| Capital Expenditure | -1.20K | 0.00 | -2.70K | -186.70K | -23.70K |
| Sale of Property, Plant, and Equipment | -- | 23.70K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.40K | 700.00 | -37.70K | -87.40K | -42.90K |
| Cash from Investing | -48.60K | 24.40K | -40.40K | -274.00K | -66.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.10K | -13.80K | -28.80K | -34.00K | -34.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -23.70K | -349.70K | -282.10K | -280.90K | -23.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.80K | -359.70K | -303.10K | -305.40K | -46.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.10K | 1.60M | 296.10K | 172.40K | 132.40K |